NDC00555-0328-05: THIORIDAZINE HYDROCHLORIDE TABLE.
THIORIDAZINE HYDROCHLORIDE TABLE. Key specifications include administration: ORAL, primary_container_type: BOTTLE, therapeutic_equivalent: SANDOZ PHARM. DIV.
AND BARR LABS.,INC., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 1000.000 TABLETS. This part is cataloged in the U.S. Government catalog under NSN 6505-00-050-3073, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | COATING FEATURE:SUGAR; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | SANDOZ PHARM. DIV. AND BARR LABS.,INC. |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 1000.000 TABLETS |
| NSN | 6505-00-050-3073 |
| THERAPEUTIC EQUIVALENT | SANDOZ PHARM. DIV. AND BARR LABS.,INC. |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | COATING FEATURE:SUGAR; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS THIORIDAZINE HYDROCHLORIDE ACTIVE INGREDIENT |